|
1.
|
Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2018
Citation: - Catheterization & Cardiovascular Interventions. 92(7):E502-E511, 2018 Dec 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abizaid A, Alves Lemos P, Barbato E, BIOSOLVE-II and III investigators, Christiansen EH, Garcia-Garcia HM, Haude M, Ince H, Kische S, Tolg R, Van Mieghem NM, Verheye S, von Birgelen C, Waksman R
|
|
2.
|
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2018
Citation: - Circulation: Cardiovascular Interventions. 11(10):e007331, 2018 Oct.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Marcusohn E, Massaro JM, Roguin A, Waksman R
|